Rexahn Pharmaceuticals Presents Additional Data for Supinoxin for the …

Rexahn Pharmaceuticals Presents Additional Data for Supinoxin for the …

"There is an accumulating body of in vitro and in vivo evidence suggesting a potential role for Supinoxin in the treatment of TNBC – a particularly aggressive and often difficult-to-treat form of breast cancer, which comprises approximately 20% of new

(Visited 1 times, 1 visits today)
4
Like
Save

Comments

Write a comment

*